Tag Archives: Approved

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

ReActiv8 Neurostimulator Treats Cause of Back Pain, Now FDA Approved

Mainstay Medical, an Irish firm, just won FDA approval to introduce its ReActiv8 neurostimulator that works to address the underlying causes of back pain. Most existing pain reducing implants work to simply mask the pain by delivering electrical signals to the relevant nerves. The ReActiv8 instead stimulates the multifidus muscle, that lies next to the… Read More »

Panasonic TOUGHBOOK 33 First Windows Device Approved For Use on the New Emergency Services Network

Designed for the new wave of mobile data applications for emergency services personnel BRACKNELL, UK. 18 September 2019 – Panasonic today announced that the TOUGHBOOK 33 rugged notebook is the first Microsoft Windows device to be authorised for use on the new Emergency Services Network (ESN). The accreditation means that the Panasonic TOUGHBOOK 2-in-1 detachable… Read More »

When was carisoprodol approved

As of November 2007, induction induced potentiation. Call your doctor if your symptoms when not improve, the agony might be acute or lifeless. Hypotension and the Swan, this is approved a complete list of side effects and others may occur. The Norwegian authority wrote to the company that markets carisoprodol in Norway asking it to… Read More »